Ì첩ÌåÓý

Elena Toschi, MD, is an Italian physician who has worked in Italy with Ele Ferrannini on insulin action and glucose metabolism in the late 1990’s. She then moved to Boston, USA to join Susan Bonner-Weir’s lab as a post-doctoral fellow working on the biology of islets of Langerhans and their regeneration. After obtaining her American medical license and specialization in Endocrinology at the joined Beth Israel Deaconess Medical Center/ Joslin program she has joined the Joslin adult clinic to work with Dr Howard Wolpert. Her clinical work has focused on use of technology in T1D to improve outcome. She has been involved in several multicenter trial on use of technology for the management of diabetes: REPLACE-BG and DIAMOND study among others. These studies have evaluated the benefit of CGM use by patients on multiple daily injections of insulin, have changed healthcare policy, with CGM now recommended to all patients with Type 1 Diabetes and CGM are now covered by Medicare. She is currently working on the use of technology to improve diabetes management and reduce the risk of hypoglycemia in the eldery with T1D (NIDDK DP3-Tango Study) in collaboration with Dr Munshi, and on restoration of hypoglycemia awareness in people with T1D and problematic hypoglycemia in collaboration with Dr Amiel. (JDRF – HARP.doc). She has been recently appointed Director of the Young Adult Clinic in the Adult Diabetes Section at Joslin Diabetes Center.